SCHEMBL13870960

SCHEMBL13870960

CCc1cc2ccc(-c3cccc(OC)c3)nc2cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.45
TOP1 P11387 1/20 0.43
TDP1 Q9NUW8 3/20 0.41
KDM4E B2RXH2 3/20 0.41
HPGD P15428 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 2/20 0.41
RAB9A P51151 2/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
WDR5 P61964 1/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870903 0.86 MAP4K4 (0.51) MAP4K4TOP1TDP1KDM4EHPGD
SCHEMBL16487821 0.86 PDGFRB (0.47) MAP4K4TOP1TDP1KDM4EHPGD
SCHEMBL13870948 0.84 KMO (0.42) TDP1KDM4EHPGDKMT2ASMN1; SMN2
SCHEMBL13399461 0.82 MAP4K4 (0.47) MAP4K4TOP1TDP1KDM4EHPGD
SCHEMBL13870935 0.79 PDGFRB (0.61) MAP4K4TOP1TDP1KDM4EKMT2A
SCHEMBL13399662 0.79 MAP4K4 (0.47) MAP4K4TOP1TDP1KDM4EHPGD
SCHEMBL13870961 0.78 NPC1 (0.44) TDP1KDM4EHPGDSMN1; SMN2MAPT
SCHEMBL3012991 0.78 MAP4K4 (0.57) MAP4K4TOP1TDP1KDM4EHPGD
SCHEMBL12313234 0.78 MAP4K4 (0.44) MAP4K4TOP1TDP1KDM4EHPGD
SCHEMBL13399544 0.77 ADORA2A (0.52) MAP4K4TOP1TDP1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 MAP4K4 3011/4885TOP1 2115/4885TDP1 1447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.